
Walmart Recall Update: Life-Threatening Warning Issued Nationwide
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
Walmart has issued multiple product recalls in the past week, including one accompanied by a life-threatening health warning.
Newsweek previously reached out to Walmart for comment regarding the recalls.
Tropicale Foods Helados Mexico and La Michoacana Ice Cream Products
As previously reported by Newsweek, Tropicale Foods, based in Ontario, California, announced last Friday a voluntary recall of select Helados Mexico and La Michoacana ice cream products.
The products were sold at Walmart stores in all 50 states and Washington, D.C.
The decision followed a label audit, which revealed that although the products list "cream" as an ingredient, they do not explicitly include "milk," which could endanger those with an allergy.
Milk is a major allergen under federal labeling laws, and its accidental presence in products poses a risk to consumers with allergies or severe sensitivities.
The recall noted that "people who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume these products."
File photo of Walmart and Sam's Club signs in Miami, Florida.
File photo of Walmart and Sam's Club signs in Miami, Florida.Doehler Dry Ingredient Solutions, LLC Member's Mark Freeze Dried Fruit Variety Pack
Doehler Dry Ingredient Solutions, LLC, recalled Member's Mark Freeze Dried Fruit Variety Pack 15-count boxes, UPC 1 93968 50900 2, due to contamination with Listeria monocytogenes, the Food and Drug Administration (FDA) announced.
Listeria can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.
Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain, and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women.
So far, no illnesses have been reported in connection with the recall.
The products were sold at select Sam's Clubs in the following states and Puerto Rico. Sam's Club is owned by Walmart Inc.
Alabama
Arizona
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Iowa
Idaho
Illinois
Indiana
Kansas
Louisiana
Maryland
Maine
Michigan
Minnesota
Missouri
Mississippi
Montana
North Carolina
North Dakota
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
Ohio
Oklahoma
Pennsylvania
South Carolina
South Dakota
Tennessee
Texas
Utah
Virginia
Wisconsin
West Virginia
Wyoming
High Noon Beach Variety Packs
High Noon recalled its Vodka Seltzer Beach Pack (12 Pack). The company announced that some of these packs contain cans that are mislabeled as CELSIUS® ASTRO VIBE™ Energy Drink. Consumption of the liquid in these cans will result in unintentional alcohol ingestion.
As reported by Newsweek, the mislabeled cans containing alcohol raise health concerns for many consumers, particularly minors and individuals who avoid alcohol for medical or religious reasons. Health officials and retailers often stress that consuming recalled items can lead to serious illness or injury.
The products were sold at select Walmart stores in Florida, Michigan, Ohio, South Carolina, Virginia, and Wisconsin.
Anyone who has purchased any of the recalled items is advised not to consume the products and to dispose of or return them to the store where possible.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Wall Street Journal
6 hours ago
- Wall Street Journal
The Heartland Whole Health Institute: A Building for Well-Being
When a prince of 18th-century Germany developed a mania for constructing palaces, he was said to have caught the Bauwurm, or building bug (literally 'building worm'). Is there a better way to describe what has happened to Alice Walton, of the family that founded Walmart? Since 2011 she has built a major art museum, a school of medicine, and an institute for health, all on a 134-acre campus in Bentonville, Ark. The diversity of these buildings, their furious ambition, and Ms. Walton's intimate involvement in their making have made her America's most interesting patron of architecture. Her Heartland Whole Health Institute, founded in 2019, has a daunting mandate: to collaborate 'with the health care industry in developing a whole-health approach that considers the needs of the whole person with the goal of preventing disease, improving health outcomes, and sustaining wellness.' This is the language of public policy and officialdom—rocky soil for visionary architecture. But Marlon Blackwell Architects, which designed the HWHI, took it seriously, showing us what a whole-health approach might mean for architecture.
Yahoo
9 hours ago
- Yahoo
Wegmans recalls cheese sold across 10 US states over listeria risk
Grocery store chain Wegmans is recalling its Medium Camembert Soft Ripened Cheese, as well as products that contain it, due to a potential listeria contamination, the U.S. Food and Drug Administration (FDA) said in a notice. In the FDA alert posted on Wednesday, Aug. 13, Wegmans said the items affected by the recall were sold between July 1 and Aug. 12 in stores located in Connecticut, Delaware, Maryland, Massachusetts, New Jersey, New York, North Carolina, Pennsylvania, Virginia and Washington, D.C. The company said the cheese was supplied to the store by Estancia Holdings from Cumming, Georgia. As of now, no illnesses have been reported in connection with the cheese recall, according to the alert. The FDA said Wegmans has placed automated phone calls to customers who purchased the cheese using their Shoppers Club card. Customers who bought the affected cheese can return it to the store's service desk for a full refund, per the notice. What products are being recalled? The FDA provided a list of products affected by the recall: Wegmans Medium Camembert Soft Ripened Cheese, 8.8-ounce, UPC: 77890-53515 with best by dates of 7/26/25, 8/12/25, and 8/19/25 Wegmans Assorted Cheese Flight, one pound, UPC: 2-77100-00000-0 Wegmans Grilling Camembert with Tapenade & Roasted Tomatoes, 10-ounce, UPC: 2-77297-00000-0 Wegmans Caramel Apple Pecan Topped Brie Cheese, 13-ounce, UPC: 2-77645-00000-3 Listeria poisoning symptoms Listeriosis, or listeria poisoning, is a foodborne bacterial infection most commonly caused by the bacterium Listeria monocytogenes, according to the Centers for Disease Control and Prevention (CDC). It is considered a serious condition and can be dangerous or life-threatening, especially to older adults, people with weak immune systems and pregnant women. Listeria is the third leading cause of death from foodborne illness in the U.S., according to the CDC. The agency estimates that the disease impacts 1,600 Americans each year, with approximately 260 people dying from those infections. Per the CDC, symptoms include: Fever Muscle aches Headache Stiff neck Confusion Loss of balance Convulsions Diarrhea Other gastrointestinal symptoms Miscarriage, stillbirth, premature delivery and/or life-threatening infection of newborn infants Death USA TODAY's Saman Shafiq and Natalie Neysa Alund contributed to this report. Fernando Cervantes Jr. is a trending news reporter for USA TODAY. Reach him at and follow him on X @fern_cerv_. This article originally appeared on USA TODAY: Wegmans recalls cheese sold in 10 US states over listeria risk
Yahoo
13 hours ago
- Yahoo
Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains
BOULDER, CO / / August 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced the launch of its HOCl-based diaper rash product for infants and children into large retailers in the United States. The antimicrobial hydrogel is being marketed and sold through Sonoma's U.S.-based distribution partner. The diaper rash product is currently carried in 3,600 Walmart stores, and certain large grocery chains. "We are excited to see our strategy of expanding into the over-the-counter space begin to take hold with our first U.S. product targeted to consumers launched into large scale retail channels," said Amy Trombly, CEO of Sonoma. "We are also pleased about the increased availability of our Microcyn technology for consumers who seek safe and effective solutions for diaper rash and other skin irritations." About Sonoma Pharmaceuticals, Inc. Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Sonoma's products are clinically proven to reduce itch, pain, scarring, and irritation safely and without damaging healthy tissue. In-vitro and clinical studies of HOCl show it to safely manage skin abrasions, lacerations, minor irritations, cuts, and intact skin. Sonoma's products are sold either directly or via partners in 55 countries worldwide and the company actively seeks new distribution partners. The company's principal office is in Boulder, Colorado, with manufacturing operations in Guadalajara, Mexico. European marketing and sales are headquartered in Roermond, Netherlands. More information can be found at For partnership opportunities, please contact busdev@ Forward-Looking Statements Except for historical information herein, matters set forth in this press release are forward-looking within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including statements about the commercial and technology progress and future financial performance of Sonoma Pharmaceuticals, Inc. and its subsidiaries (the "company"). These forward-looking statements are identified by the use of words such as "continue," "develop," "anticipate," "expect" and "expand," among others. Forward-looking statements in this press release are subject to certain risks and uncertainties inherent in the company's business that could cause actual results to vary, including such risks that regulatory clinical and guideline developments may change, scientific data may not be sufficient to meet regulatory standards or receipt of required regulatory clearances or approvals, clinical results may not be replicated in actual patient settings, protection offered by the company's patents and patent applications may be challenged, invalidated or circumvented by its competitors, the available market for the company's products will not be as large as expected, the company's products will not be able to penetrate one or more targeted markets, revenues will not be sufficient to meet the company's cash needs, fund further development, the ability to meet a multitude of diverse regulatory and marketing requirements in different countries and municipalities, and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission. The company disclaims any obligation to update these forward-looking statements, except as required by law. Sonoma Pharmaceuticals™ and Microcyn® are trademarks or registered trademarks of Sonoma Pharmaceuticals, Inc. All other trademarks and service marks are the property of their respective owners. Media and Investor Contact: Sonoma Pharmaceuticals, Website: us on LinkedIn: us on Instagram: us on Facebook: SOURCE: Sonoma Pharmaceuticals, Inc. View the original press release on ACCESS Newswire